Port-A-Cath - Vascular port/catheter
Access comprehensive regulatory information for Port-A-Cath - Vascular port/catheter in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is sponsored by Smiths Medical Australasia Pty Ltd, manufactured by Smiths Medical ASD Inc in United States of America. The device registration started on March 27, 2024.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.
The PORT-A-CATH, PORT-A-CATH II, P.A.S. PORT T2 POWER P.A.C. implantable venous access systems are designed to permit repeated access to the vascular system for the parenteral delivery of medications, fluids, and nutritional solutions; for the sampling of venous blood; and power injection of contrast media.